Pfizer reportedly started manufacturing hundreds of thousands of Covid-19 vaccines ahead of expecting approval in the US and elsewhere.
Keystone/Dave Weaver
The Swiss therapeutic products agency has begun reviewing another anti-Covid 19 vaccine in the rolling submission procedure.
This content was published on
1 minute
swissinfo.ch/ug
Português
pt
Swissmedic acelera processo de segunda vacina anti-viral
Swissmedic said the United States pharmaceutical company Pfizer submitted an application for the authorisation of a vaccine which is based on the mRNA technology last week.
The agency added it is fast-tracking all applications connected with the Covid-19 pandemic, assigning extra staff to this task so that content checks and, in particular, user safety are not compromised.
The criteria for reviewing safety, efficacy and quality remain unchanged, according to Claus Bolte, head of Swissmedic’s authorisation division.
“The data packages for the vaccine candidates will be reviewed just as comprehensively, but faster. As a result, we can shorten the waiting times between the development stages during the review,” Bolte said in a statementExternal link published on Monday.
Two weeks ago, the Swiss authorities started assessing an application for a vaccine developed by the British-Swedish company AstraZeneca and Oxford University.
Switzerland has also signed a deal with US biotech firm Moderna to secure early access to 4.5 million doses of its Covid-19 vaccine.
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
Over 50 former diplomats blast Switzerland for ‘silence’ on Israel
This content was published on
In a joint letter, 55 former diplomats have expressed their shock at Switzerland’s “silence and passivity” regarding Israel’s “war crimes” in Gaza.
Swiss Solidarity donations surpass CHF4 million for landslide victims
This content was published on
As of Sunday morning, Swiss Solidarity’s provisional donation amount for the landslide area was around CHF4.3 million ($5.2 million).
Swiss aid expert criticises Gaza Humanitarian Foundation
This content was published on
The aid work of the Gaza Humanitarian Foundation is insufficient says Swiss government Delegate for Humanitarian Aid Dominik Stillhart.
Danger in Lötschental valley landslide area remains high
This content was published on
According to the authorities in canton Valais, the danger in the landslide area in the Lötschental valley remains very high on Sunday.
Swiss president visits region affected by glacier collapse
This content was published on
Swiss President Karin Keller-Sutter spoke with communities affected by the Birch glacier collapse, which buried the village of Blatten.
This content was published on
On Saturday the Lake Geneva, Valais and Basel regions are expected to record the first tropical day of the year, with temperatures exceeding 30°C.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Covid cure further away than hoped, says Novartis chief
This content was published on
Swiss pharmaceutical firm Novartis has rowed back on earlier predictions that a drug to combat coronavirus could be on the horizon.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.